Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BUSZMAN, Pawel")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 27

  • Page / 2
Export

Selection :

  • and

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS) : a randomised non-inferiority trial. CommentaryWAKSMAN, Ron; WINDECKER, Stephan; EBERLI, Franz et al.Lancet (British edition). 2008, Vol 372, Num 9644, issn 0140-6736, 1126-1128, 1163-1173 [14 p.]Article

Local delivery of enoxaparin to decrease restenosis after stenting : Results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment Study (The POLONIA Study)KIESZ, R. Stefan; BUSZMAN, Pawel; MARTIN, Jack L et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 1, pp 26-31, issn 0009-7322Article

The three year follow-up of the randomised all-comers trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)WYKRZYKOWSKA, Joanna; SERRUYS, Patrick; DI MARIO, Carlo et al.EuroIntervention. 2011, Vol 7, Num 7, pp 789-795, issn 1774-024X, 7 p.Article

Cardiomyoeyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cellsWOJAKOWSKI, Wojciech; TENDERA, Michal; KALUZA, Grzegorz et al.International journal of oncology. 2010, Vol 37, Num 2, pp 237-247, issn 1019-6439, 11 p.Article

The Impact of Body Mass Index on the One Year Outcomes of Patients Treated by Percutaneous Coronary Intervention With Biolimus- and Sirolimus-Eluting Stents (from the LEADERS Trial)SARNO, Giovanna; GARG, Scot; MORICE, Marie-Claude et al.The American journal of cardiology. 2010, Vol 105, Num 4, pp 475-479, issn 0002-9149, 5 p.Article

The outcome of bifurcation lesion stenting using a biolimus- eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymerGARG, Scot; WYKRZYKOWSKA, Joanna; EBERLI, Franz et al.EuroIntervention. 2011, Vol 6, Num 8, pp 928-935, issn 1774-024X, 8 p.Article

Effects of the Direct Lipoprotein-Associated Phospholipase A2Inhibitor Darapladib on Human Coronary Atherosclerotic PlaqueSERRUYS, Patrick W; GARCIA-GARCIA, Héctor M; VON BIRGELEN, Clemens et al.Circulation (New York, N.Y.). 2008, Vol 118, Num 11, pp 1172-1182, issn 0009-7322, 11 p.Article

Actinomycin-eluting stent for coronary revascularization. A randomized feasibility and safety study: The ACTION TrialSERRUYS, Patrick W; ORMISTON, John A; POLONSKI, Lech et al.Journal of the American College of Cardiology. 2004, Vol 44, Num 7, pp 1363-1367, issn 0735-1097, 5 p.Article

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymerGARG, Scot; SARNO, Giovanna; WIJNS, William et al.EuroIntervention. 2010, Vol 6, Num 2, pp 233-239, issn 1774-024X, 7 p.Article

Biolimus-eluting biodegradable polymer versus sirolimus- eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudyWYKRZYKOWSKA, Joanna J; RÄBER, Lorenz; WIJNS, William et al.EuroIntervention. 2009, Vol 5, Num 3, pp 310-317, issn 1774-024X, 8 p.Article

Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with Ischemic cardiomyopathyBUSZMAN, Pawel; SZKROBKA, Iwona; TENDERA, Michał et al.The American journal of cardiology. 2007, Vol 99, Num 1, pp 36-41, issn 0002-9149, 6 p.Article

Guidelines on the management of stable angina pectoris: executive summary : The task force on the management of stable angina pectoris of the european society of cardiologyFOX, Kim; ARDISSINO, Diego; MORAIS, Joao et al.European heart journal. 2006, Vol 27, Num 11, pp 1341-1381, issn 0195-668X, 41 p.Article

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the all-comers LEADERS trialWYKRZYKOWSKA, Joanna J; GARG, Scot; CORTI, Roberto et al.EuroIntervention. 2011, Vol 7, Num 5, pp 605-613, issn 1774-024X, 9 p.Article

Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the 'All-Comers' LEADERS TrialWYKRZYKOWSKA, Joanna J; GARG, Scot; KLAUSS, Volker et al.Circulation. Cardiovascular interventions. 2011, Vol 4, Num 1, pp 47-56, issn 1941-7640, 10 p.Article

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialG STEFANINI, Giulio; KALESAN, Bindu; MORICE, Marie-Claude et al.Lancet (British edition). 2011, Vol 378, Num 9807, pp 1940-1948, issn 0140-6736, 9 p.Article

Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) TrialWYKRZYKOWSKA, Joanna J; GARG, Scot; CORTI, Roberto et al.Journal of the American College of Cardiology. 2010, Vol 56, Num 4, pp 272-277, issn 0735-1097, 6 p.Article

Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function : The total occlusion study of Canada (TOSCA)-2 trialDZAVIK, Vladimir; BULLER, Christopher E; THOMAS, Boban et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 23, pp 2449-2457, issn 0009-7322, 9 p.Article

4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents: A Report From the RESOLUTE All-Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)TANIWAKI, Masanori; STEFANINI, Giulio G; SILBER, Sigmund et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 16, pp 1617-1625, issn 0735-1097, 9 p.Article

Controlled Reperfusion with Intravenous Bivalirudin and Intracoronary Abciximab Combination Therapy in the Porcine Myocardial Infarction ModelBUSZMAN, Piotr P; WOJAKOWSKI, Wojciech; GRANADA, Juan F et al.Thrombosis research. 2012, Vol 130, Num 2, pp 265-272, issn 0049-3848, 8 p.Article

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) TrialTENDERA, Michał; WOJAKOWSKI, Wojciech; GRAJEK, Stefan et al.European heart journal. 2009, Vol 30, Num 11, pp 1313-1321, issn 0195-668X, 9 p.Article

Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical RevascularizationBUSZMAN, Pawel E; KIESZ, Stefan R; MILEWSKI, Krzysztof et al.Journal of the American College of Cardiology. 2008, Vol 51, Num 5, pp 538-545, issn 0735-1097, 8 p.Article

Percutaneous coronary intervention in the Occluded Artery Trial: Procedural success, hazard, and outcomes over 5 yearsBULLER, Christopher E; RANKIN, Jamie M; MICHALIS, Lampros K et al.The American heart journal. 2009, Vol 158, Num 3, pp 408-415, issn 0002-8703, 8 p.Article

Mobilization of Bone Marrow-Derived Oct-4+ SSEA-4+ Very Small Embryonic-Like Stem Cells in Patients With Acute Myocardial Infarction. CommentaryWOJAKOWSKI, Wojciech; TENDERA, Michał; OCHATA, Andrzej et al.Journal of the American College of Cardiology. 2008, Vol 53, Num 1, pp 1-9, issn 0735-1097, 9 p.Article

Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury : EVBM 2001 Part IWOJAKOWSKI, Wojciech; TENDERA, Michal; PASLAWSKI, Robert et al.Thrombosis and haemostasis. 2012, Vol 108, Num 3, pp 464-475, issn 0340-6245, 12 p.Article

The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents: A Substudy of the RESOLUTE All Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)STEFANINI, Giulio G; SERRUYS, Patrick W; LINKE, Axel et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 22, pp 2221-2232, issn 0735-1097, 12 p.Article

  • Page / 2